About VWR (NASDAQ:VWR)
VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC. The Americas segment consists of operations located principally in the United States and Canada, as well as in Puerto Rico, Mexico and select countries in Central and South America, including Costa Rica, Brazil, Argentina and Chile. As of December 31, 2016, the Americas segment included 67 facilities located in eight countries. As of December 31, 2016, the EMEA-APAC segment consisted of its operations located principally in Europe, as well as in certain Asia-Pacific countries, and included 110 facilities located in 26 countries. The Company's portfolio includes chemicals, reagents, consumables, durable products and scientific equipment and instruments.
Industry, Sector and Symbol
Industry Medical Equipment, Supplies & Distribution
Trailing P/E Ratio17.32
Forward P/E Ratio17.97
Sales & Book Value
Annual Sales$4.51 billion
Price / Sales0.97
Cash Flow$2.71 per share
Price / Cash12.28
Book Value$12.98 per share
Price / Book2.56
Net Income$148.20 million
Return on Equity11.79%
Return on Assets3.67%
VWR (NASDAQ:VWR) Frequently Asked Questions
What is VWR's stock symbol?
VWR trades on the NASDAQ under the ticker symbol "VWR."
How were VWR's earnings last quarter?
VWR Corp (NASDAQ:VWR) released its quarterly earnings results on Tuesday, November, 7th. The medical research company reported $0.54 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.46 by $0.08. The medical research company had revenue of $1.20 billion for the quarter, compared to the consensus estimate of $1.16 billion. VWR had a net margin of 4.11% and a return on equity of 11.79%. The company's quarterly revenue was up 5.2% on a year-over-year basis. During the same period last year, the firm earned $0.44 earnings per share. View VWR's Earnings History.
When will VWR make its next earnings announcement?
Where is VWR's stock going? Where will VWR's stock price be in 2017?
3 equities research analysts have issued 1-year price objectives for VWR's shares. Their predictions range from $26.00 to $32.00. On average, they anticipate VWR's stock price to reach $29.00 in the next year. View Analyst Ratings for VWR.
What are Wall Street analysts saying about VWR stock?
Here are some recent quotes from research analysts about VWR stock:
- 1. According to Zacks Investment Research, "VWR’s third-quarter earnings report was quite impressive, with both the top and the bottom line beating the Zacks Consensus Estimate. Geographically, the company recorded growth in both Americas and EMEA-APAC during the reported quarter driven by strong sales of equipment and instrumentation. Management is also looking forward to the long-term synergy benefits from the proposed merger with Avantor. The merger is expected to strengthen VWR’s business across the Americas and Europe. While we await the merger to close in the fourth quarter of 2017 we note that the stock price has already reached close to Avantor’s offer price and hence the short-term upside potential of VWR is limited now. On the flip side, a drop in organic sales growth in the Americas on account of the adverse weather conditions in Puerto Rico, Texas and Florida was disappointing. VWR’s poor operating margin scenario also raises concern." (11/9/2017)
- 2. Jefferies Group LLC analysts commented, "We continue to like VWR's competitive position in the highly fragmented research distribution landscape & see scope for improved core growth over the coming years on stronger market share gains, particularly in the Industrial arena. Sentiment remains weak, in our view, with much of the debate still stuck on Merck KGaA what-ifs. Greater clarity on that front would be cause for rerating, in our view... Qualitative commentary on the call pointed to robust trends in EMEA across the Industrial channel (>+10%) entering the year. The timing of Easter will benefit EMEA in 1Q17 (+2 extra days / ~+4% impact), which will go the other way in 2Q17. In the Americas region, 1Q17 core growth should improve from 4Q (-1%), but still faces a tough year-ago comparison (+7.6% in 1Q16)." (2/27/2017)
Are investors shorting VWR?
VWR saw a increase in short interest in the month of November. As of November 15th, there was short interest totalling 957,513 shares, an increase of 51.9% from the October 31st total of 630,542 shares. Based on an average trading volume of 723,291 shares, the short-interest ratio is currently 1.3 days.
Who are some of VWR's key competitors?
Some companies that are related to VWR include Steris (STE), Bio-Rad Laboratories (BIO), West Pharmaceutical Services (WST), Hill-Rom (HRC), DexCom (DXCM), ICU Medical (ICUI), Integra LifeSciences (IART), LivaNova (LIVN), Globus Medical (GMED), Neogen (NEOG), NuVasive (NUVA), Haemonetics (HAE), Inogen (INGN), Halyard Health (HYH), Nevro (NVRO), CONMED (CNMD), MiMedx Group (MDXG) and OraSure Technologies (OSUR).
Who are VWR's key executives?
VWR's management team includes the folowing people:
- Gregory L. Cowan CPA, Chief Financial Officer, Senior Vice President (Age 63)
- Gerard J. Christian, Senior Vice President, Chief Global Business Services Officer (Age 48)
- Nils Clausnitzer, Senior Vice President, President - EMEA-APAC Lab Business (Age 47)
- Ulf Kepper, Senior Vice President - VWR Services (Age 51)
- Mark T. McLoughlin, Senior Vice President, President - U.S. Lab and Distribution Services (Age 61)
- Douglas J. Pitts, Vice President, Corporate Controller (Age 58)
- George Van Kula, Senior Vice President - Human Resources, General Counsel, Secretary (Age 53)
- Harry M. Jansen Kraemer Jr., Chairman of the Board (Age 62)
- Manuel A. Brocke-benz, President, Chief Executive Officer, Director (Age 58)
- Nicholas W. Alexos CPA, Independent Director (Age 53)
Who owns VWR stock?
VWR's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Schroder Investment Management Group (2.27%), Russell Investments Group Ltd. (0.87%), Chartwell Investment Partners LLC (0.36%), SG Americas Securities LLC (0.15%), Norris Perne & French LLP MI (0.13%) and Colony Group LLC (0.10%). Company insiders that own VWR stock include Madison Dearborn Partners Llc, Manuel Brocke-Benz, Nicholas W Alexos and Timothy P Sullivan. View Institutional Ownership Trends for VWR.
Who sold VWR stock? Who is selling VWR stock?
VWR's stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Buffington Mohr McNeal, Chartwell Investment Partners LLC, Norris Perne & French LLP MI and Colony Group LLC. View Insider Buying and Selling for VWR.
Who bought VWR stock? Who is buying VWR stock?
VWR's stock was acquired by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Schroder Investment Management Group, Crossmark Global Holdings Inc. and Aperio Group LLC. View Insider Buying and Selling for VWR.
How do I buy VWR stock?
Shares of VWR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is VWR's stock price today?
One share of VWR stock can currently be purchased for approximately $33.25.
How big of a company is VWR?
VWR has a market capitalization of $4.38 billion and generates $4.51 billion in revenue each year. The medical research company earns $148.20 million in net income (profit) each year or $1.14 on an earnings per share basis. VWR employs 10,200 workers across the globe.
How can I contact VWR?
VWR's mailing address is Building One, 100 Matsonford Rd Ste 200, RADNOR, PA 19087-4558, United States. The medical research company can be reached via phone at +1-610-3861700 or via email at [email protected]
MarketBeat Community Rating for VWR (VWR)MarketBeat's community ratings are surveys of what our community members think about VWR and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
VWR (NASDAQ:VWR) Earnings History and Estimates Chart
VWR (NASDAQ VWR) Earnings History by Quarter
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/23/2018|| || || || || || || || |
|11/7/2017||Q3 2017||$0.46||$0.54||$1.16 billion||$1.20 billion||View||N/A|
|7/31/2017||Q2 2017||$0.45||$0.49||$1.16 billion||$1.18 billion||View||N/A|
|5/5/2017||Q1 2017||$0.41||$0.44||$1.11 billion||$1.14 billion||View||N/A|
|2/24/2017||Q416||$0.44||$0.45||$1.15 billion||$1.13 billion||View||N/A|
|11/3/2016||Q316||$0.43||$0.44||$1.15 billion||$1.14 billion||View||N/A|
|8/4/2016||Q216||$0.41||$0.42||$1.14 billion||$1.15 billion||View||Listen|
|5/5/2016||$0.38||$0.40||$1.07 billion||$1.10 billion||View||N/A|
|2/25/2016||Q415||$0.42||$0.47||$1.08 billion||$1.10 billion||View||Listen|
|11/5/2015||Q315||$0.38||$0.38||$1.09 million||$1.10 billion||View||N/A|
|8/12/2015||Q2||$0.33||$0.34||$1.07 billion||$1.08 billion||View||Listen|
|5/14/2015||Q1||$0.33||$0.33||$1.02 billion||$1.03 billion||View||Listen|
|3/4/2015||Q414||$0.37||$0.42||$1.08 billion||$1.10 billion||View||N/A|
|11/6/2014||Q3 14||$0.26||$1.11 billion||View||N/A|
VWR (NASDAQ:VWR) Earnings Estimates
Current Year EPS Consensus Estimate: $1.85 EPS
Next Year EPS Consensus Estimate: $1.96 EPS
Dividend History for VWR (NASDAQ:VWR)
No dividend announcements for this company have been tracked by MarketBeat.com
VWR (NASDAQ VWR) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 35.50%
Institutional Ownership Percentage: 96.66%
VWR (NASDAQ VWR) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|9/15/2016||Manuel Brocke-Benz||Insider||Buy||368||$27.16||$9,994.88|| |
|8/15/2016||Manuel Brocke-Benz||Insider||Buy||333||$29.60||$9,856.80|| |
|7/15/2016||Manuel Brocke-Benz||CEO||Buy||333||$29.84||$9,936.72|| |
|6/15/2016||Manuel Brocke-Benz||CEO||Buy||335||$29.74||$9,962.90|| |
|5/24/2016||Madison Dearborn Partners Llc||Major Shareholder||Sell||8,000,000||$27.25||$218,000,000.00|| |
|5/16/2016||Manuel Brocke-Benz||CEO||Buy||343||$28.85||$9,895.55|| |
|4/15/2016||Manuel Brocke-Benz||CEO||Buy||373||$26.38||$9,839.74|| |
|4/5/2016||Nicholas W Alexos||Director||Sell||9,200,000||$25.85||$237,820,000.00|| |
|3/15/2016||Manuel Brocke-Benz||CEO||Buy||396||$24.86||$9,844.56|| |
|2/16/2016||Manuel Brocke-Benz||CEO||Buy||417||$23.74||$9,899.58|| |
|1/15/2016||Manuel Brocke-Benz||CEO||Buy||395||$25.02||$9,882.90|| |
|11/25/2015||Madison Dearborn Partners Llc||Major Shareholder||Sell||1,650,000||$25.75||$42,487,500.00|| |
|11/16/2015||Nicholas W Alexos||Director||Sell||11,000,000||$25.75||$283,250,000.00|| |
|8/24/2015||Manuel Brocke-Benz||CEO||Buy||3,825||$26.07||$99,717.75|| |
|6/24/2015||Timothy P Sullivan||Director||Sell||2,400,000||$25.23||$60,552,000.00|| |
|6/9/2015||Nicholas W Alexos||Director||Sell||16,000,000||$25.23||$403,680,000.00|| |
|11/24/2014||Manuel Brocke-Benz||Insider||Buy||1,000||$26.18||$26,180.00|| |
VWR (NASDAQ VWR) News Headlines
|BioHealth Innovation Appoints Three New Board Members|
www.bizjournals.com - December 12 at 4:44 PM
|VWR Corp (VWR) Given Average Recommendation of "Hold" by Brokerages|
www.americanbankingnews.com - December 8 at 8:20 AM
|VWR Corporation (VWR) Short Interest Up 51.9% in November|
www.americanbankingnews.com - November 29 at 1:34 AM
|Avantor Completes Acquisition of VWR (VWR)|
www.streetinsider.com - November 23 at 6:17 PM
|Avantor® Completes Acquisition of VWR|
finance.yahoo.com - November 23 at 5:06 AM
|$6.5B sale of Main Line laboratory products supplier is a done deal|
finance.yahoo.com - November 23 at 5:06 AM
|Stocks Under Scanner in the Medical Research Space -- PRA Health Sciences, VWR Corp., Quest Diagnostics, and Laboratory Corp. of America|
www.bizjournals.com - November 20 at 12:07 PM
|Tracking John Paulson's Paulson & Company Portfolio - Q3 2017 Update|
seekingalpha.com - November 18 at 10:11 AM
|Reviewing VWR Corporation (VWR) & Its Peers|
www.americanbankingnews.com - November 16 at 10:28 AM
|VWR Corporation (VWR) Short Interest Down 41.9% in October|
www.americanbankingnews.com - November 14 at 2:26 AM
|VWR Corporation (VWR) Receives Consensus Recommendation of "Hold" from Analysts|
www.americanbankingnews.com - November 13 at 8:14 AM
|Analyzing VWR Corporation (VWR) and Zimmer Biomet Holdings (ZBH)|
www.americanbankingnews.com - November 12 at 5:26 AM
|VWR Corp (VWR) a Hold on Uninspiring Earnings Momentum|
investorplace.com - November 9 at 4:23 PM
|VWR Corporation (VWR) Stock Rating Upgraded by Zacks Investment Research|
www.americanbankingnews.com - November 9 at 1:00 PM
| Analysts Expect VWR Corporation (VWR) Will Post Quarterly Sales of $1.17 Billion|
www.americanbankingnews.com - November 8 at 9:33 AM
|VWR Corporation (VWR) Posts Quarterly Earnings Results, Beats Expectations By $0.08 EPS|
www.americanbankingnews.com - November 7 at 1:59 PM
|VWR Corporation Reports Third Quarter 2017 Financial Results|
finance.yahoo.com - November 7 at 1:23 PM
|VWR beats 3Q profit forecasts|
finance.yahoo.com - November 7 at 1:23 PM
|$0.46 EPS Expected for VWR Corporation (VWR) This Quarter|
www.americanbankingnews.com - November 6 at 9:59 AM
|Comparing VWR Corporation (VWR) and The Competition|
www.americanbankingnews.com - November 4 at 8:22 AM
|Investor Expectations to Drive Momentum within VWR, The Michaels Companies, KalVista Pharmaceuticals, PACCAR, Jaguar Health, and CPI Card Group – Discovering Underlying Factors of Influence|
finance.yahoo.com - November 1 at 10:41 AM
|VWR Corporation (VWR) Set to Announce Earnings on Tuesday|
www.americanbankingnews.com - October 31 at 2:48 PM
|Zymo Research and VWR Team Up in Strategic Supplier Partnership|
finance.yahoo.com - October 31 at 12:00 PM
|VWR Corporation to Report Third Quarter 2017 Results on November 7, 2017|
finance.yahoo.com - October 28 at 8:36 AM
|VWR Corp. breached its 50 day moving average in a Bearish Manner : VWR-US : October 24, 2017|
finance.yahoo.com - October 24 at 12:12 PM
|One of Wall Street's Favorite Metrics Is Now Getting Mocked|
www.bloomberg.com - October 20 at 4:34 PM
|VWR Corporation (VWR) Receives Consensus Rating of "Hold" from Analysts|
www.americanbankingnews.com - October 19 at 6:46 AM
|VWR Corporation (VWR) & Its Peers Critical Analysis|
www.americanbankingnews.com - October 19 at 6:26 AM
|VWR Corporation (VWR) Expected to Post Quarterly Sales of $1.18 Billion|
www.americanbankingnews.com - October 19 at 4:48 AM
|Frothy leveraged loans may get whipped up by regulatory rollback|
www.bloomberg.com - October 18 at 4:16 PM
|VWR Corporation (VWR) Downgraded to "Strong Sell" at BidaskClub|
www.americanbankingnews.com - October 14 at 12:54 PM
|VWR Corp. – Value Analysis (NASDAQ:VWR) : October 13, 2017|
finance.yahoo.com - October 14 at 9:20 AM
|VWR Corp. breached its 50 day moving average in a Bullish Manner : VWR-US : October 12, 2017|
finance.yahoo.com - October 12 at 9:57 AM
|Zacks Investment Research Lowers VWR Corporation (VWR) to Hold|
www.americanbankingnews.com - October 5 at 6:58 PM
|VWR Announces New Kitting Center in Czech Republic to Support Customers Globally|
finance.yahoo.com - October 3 at 2:42 PM
|VWR's New Kitting Center in Czech Republic to Boost EMEA Arm|
finance.yahoo.com - October 3 at 2:42 PM
|VWR Sales Team Helps Raise $12,000 for Duke Children's|
finance.yahoo.com - October 3 at 2:42 PM
|Technical Snapshots for These Medical Research Stocks -- VWR Corp., China Cord Blood, Laboratory Corp. of ... - PR Newswire (press release)|
www.prnewswire.com - October 2 at 8:21 AM
|$1.18 Billion in Sales Expected for VWR Corporation (VWR) This Quarter|
www.americanbankingnews.com - October 1 at 1:30 PM
|Head-To-Head Survey: VWR Corporation (VWR) & DENTSPLY SIRONA (XRAY)|
www.americanbankingnews.com - September 28 at 6:24 AM
|VWR's Jim Rubbo Recognized by The M&A Advisor|
finance.yahoo.com - September 23 at 10:55 AM
|LPC: Euro loan doubled to €1bn on VWR buyout at expense of dollars|
www.reuters.com - September 19 at 3:57 PM
|San Antonio-based biotech claims Houston space, remains committed to Alamo City|
www.bizjournals.com - September 19 at 3:57 PM
|Microbial Identification Market Worth 3.00 Billion USD by 2022|
www.marketwatch.com - September 19 at 3:57 PM
|Euro loan doubled to €1bn on VWR buyout at expense of dollars|
www.nasdaq.com - September 19 at 3:57 PM
|Dental Faces Regulatory Challenges: Only 5 Stocks to Pick|
finance.yahoo.com - September 13 at 11:12 AM
|CryoLife (CRY) vs. VWR Corporation (VWR) Head-To-Head Review|
www.americanbankingnews.com - September 10 at 10:22 PM
| Analysts Expect VWR Corporation (VWR) to Announce $0.46 Earnings Per Share|
www.americanbankingnews.com - September 10 at 4:08 AM
|LPC-VWR launches US$7.75bn buyout financing|
www.reuters.com - September 6 at 10:09 AM
|Avantor Performance Materials Holdings, LLC -- Moody's downgrades Avantor, Inc.'s CFR to B3; outlook negative|
finance.yahoo.com - September 6 at 10:09 AM
VWR (NASDAQ:VWR) SEC Filings
This page is loading this company's SEC Filings. Please wait...
VWR (NASDAQ:VWR) Income Statement, Balance Sheet and Cash Flow Statement
VWR (NASDAQ VWR) Stock Chart for Sunday, December, 17, 2017